Analysis of promoter methylation suggests that epigenetic regulation of Cyclin D2 is stronger in astrocytomas than in medulloblastomas, while epigenetic regulation of PTCH1 is weak in both tumors. This evidence concerns the gene CCND2 and astrocytoma (excluding glioblastoma).